425 related articles for article (PubMed ID: 20031087)
1. The clinical effectiveness and cost-effectiveness of testing for cytochrome P450 polymorphisms in patients with schizophrenia treated with antipsychotics: a systematic review and economic evaluation.
Fleeman N; McLeod C; Bagust A; Beale S; Boland A; Dundar Y; Jorgensen A; Payne K; Pirmohamed M; Pushpakom S; Walley T; de Warren-Penny P; Dickson R
Health Technol Assess; 2010 Jan; 14(3):1-157, iii. PubMed ID: 20031087
[TBL] [Abstract][Full Text] [Related]
2. The cost effectiveness of long-acting/extended-release antipsychotics for the treatment of schizophrenia: a systematic review of economic evaluations.
Achilla E; McCrone P
Appl Health Econ Health Policy; 2013 Apr; 11(2):95-106. PubMed ID: 23494934
[TBL] [Abstract][Full Text] [Related]
3. The clinical effectiveness and cost-effectiveness of genotyping for CYP2D6 for the management of women with breast cancer treated with tamoxifen: a systematic review.
Fleeman N; Martin Saborido C; Payne K; Boland A; Dickson R; Dundar Y; Fernández Santander A; Howell S; Newman W; Oyee J; Walley T
Health Technol Assess; 2011 Sep; 15(33):1-102. PubMed ID: 21906462
[TBL] [Abstract][Full Text] [Related]
4. The clinical effectiveness and cost-effectiveness of the PROGENSA® prostate cancer antigen 3 assay and the Prostate Health Index in the diagnosis of prostate cancer: a systematic review and economic evaluation.
Nicholson A; Mahon J; Boland A; Beale S; Dwan K; Fleeman N; Hockenhull J; Dundar Y
Health Technol Assess; 2015 Oct; 19(87):i-xxxi, 1-191. PubMed ID: 26507078
[TBL] [Abstract][Full Text] [Related]
5. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.
Picot J; Jones J; Colquitt JL; Gospodarevskaya E; Loveman E; Baxter L; Clegg AJ
Health Technol Assess; 2009 Sep; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018
[TBL] [Abstract][Full Text] [Related]
6. Computerised decision support systems in order communication for diagnostic, screening or monitoring test ordering: systematic reviews of the effects and cost-effectiveness of systems.
Main C; Moxham T; Wyatt JC; Kay J; Anderson R; Stein K
Health Technol Assess; 2010 Oct; 14(48):1-227. PubMed ID: 21034668
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome p450 phenotyping/genotyping in patients receiving antipsychotics: useful aid to prescribing?
Dahl ML
Clin Pharmacokinet; 2002; 41(7):453-70. PubMed ID: 12083975
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450 testing for prescribing antipsychotics in adults with schizophrenia: systematic review and meta-analyses.
Fleeman N; Dundar Y; Dickson R; Jorgensen A; Pushpakom S; McLeod C; Pirmohamed M; Walley T
Pharmacogenomics J; 2011 Feb; 11(1):1-14. PubMed ID: 20877299
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research.
Arranz MJ; de Leon J
Mol Psychiatry; 2007 Aug; 12(8):707-47. PubMed ID: 17549063
[TBL] [Abstract][Full Text] [Related]
10. Systematic review of the methods of health economic models assessing antipsychotic medication for schizophrenia.
Jin H; Tappenden P; Robinson S; Achilla E; Aceituno D; Byford S
PLoS One; 2020; 15(7):e0234996. PubMed ID: 32649663
[TBL] [Abstract][Full Text] [Related]
11. A Systematic Review of Economic Models Across the Entire Schizophrenia Pathway.
Jin H; Tappenden P; Robinson S; Achilla E; MacCabe JH; Aceituno D; Byford S
Pharmacoeconomics; 2020 Jun; 38(6):537-555. PubMed ID: 32144726
[TBL] [Abstract][Full Text] [Related]
12. Systematic Literature Review of the Methods Used to Compare Newer Second-Generation Agents for the Management of Schizophrenia: A focus on Health Technology Assessment.
Kruse G; Wong BJ; Duh MS; Lefebvre P; Lafeuille MH; Fastenau JM
Pharmacoeconomics; 2015 Oct; 33(10):1049-67. PubMed ID: 25963579
[TBL] [Abstract][Full Text] [Related]
13. Clinical effectiveness and cost-effectiveness of stem cell transplantation in the management of acute leukaemia: a systematic review.
Ashfaq K; Yahaya I; Hyde C; Andronis L; Barton P; Bayliss S; Chen YF
Health Technol Assess; 2010 Dec; 14(54):iii-iv, ix-xi, 1-141. PubMed ID: 21138675
[TBL] [Abstract][Full Text] [Related]
14. CYP2D6 genotyping for psychiatric patients treated with risperidone: considerations for cost-effectiveness studies.
Rodríguez-Antona C; Gurwitz D; de Leon J; Llerena A; Kirchheiner J; de Mesa EG; Ibarreta D
Pharmacogenomics; 2009 Apr; 10(4):685-99. PubMed ID: 19374522
[TBL] [Abstract][Full Text] [Related]
15. The clinical effectiveness and cost-effectiveness of technologies used to visualise the seizure focus in people with refractory epilepsy being considered for surgery: a systematic review and decision-analytical model.
Burch J; Hinde S; Palmer S; Beyer F; Minton J; Marson A; Wieshmann U; Woolacott N; Soares M
Health Technol Assess; 2012; 16(34):1-157, iii-iv. PubMed ID: 22985954
[TBL] [Abstract][Full Text] [Related]
16. CYP450 pharmacogenetic treatment strategies for antipsychotics: a review of the evidence.
Ravyn D; Ravyn V; Lowney R; Nasrallah HA
Schizophr Res; 2013 Sep; 149(1-3):1-14. PubMed ID: 23870808
[TBL] [Abstract][Full Text] [Related]
17. Testing for cytochrome P450 polymorphisms in adults with non-psychotic depression treated with selective serotonin reuptake inhibitors (SSRIs).
Matchar DB; Thakur ME; Grossman I; McCrory DC; Orlando LA; Steffens DC; Goldstein DB; Cline KE; Gray RN
Evid Rep Technol Assess (Full Rep); 2007 Jan; (146):1-77. PubMed ID: 17764209
[TBL] [Abstract][Full Text] [Related]
18. Intensity-modulated radiotherapy for the treatment of prostate cancer: a systematic review and economic evaluation.
Hummel S; Simpson EL; Hemingway P; Stevenson MD; Rees A
Health Technol Assess; 2010 Oct; 14(47):1-108, iii-iv. PubMed ID: 21029717
[TBL] [Abstract][Full Text] [Related]
19. Economic evaluations on the use of aripiprazole for patients with schizophrenia: A systematic review.
Henrique ICB; de Mendonça Lima T; de Melo DO; Aguiar PM
J Clin Pharm Ther; 2020 Feb; 45(1):1-15. PubMed ID: 31436857
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics as a tool in the therapy of schizophrenia.
Wilffert B; Zaal R; Brouwers JR
Pharm World Sci; 2005 Feb; 27(1):20-30. PubMed ID: 15861931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]